Issue: 2017 > May > case report

Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of

E.F.E. Wenstedt, C.J. Huysentruyt, C.J.A.M. Konings
AbstractFull textPDF


In contrast with uraemic calciphylaxis in end-stage renal disease, causes of and risk factors for non-uraemic calciphylaxis are relatively unknown to clinicians and have yet to become fully established. This report describes a case of non-uraemic calciphylaxis, in which the use of acenocoumarol might have been a risk factor. It is important to raise awareness about this association among
clinicians, as vitamin K antagonists have to be stopped for an optimal treatment of this severe condition.